ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

XERS Xeris Biopharma Holdings Inc

1.93
0.07 (3.76%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Xeris Biopharma Holdings Inc XERS NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.07 3.76% 1.93 13:00:11
始値 安値 高値 終値 前日終値
1.90 1.84 1.93 1.89 1.86
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0220:00BWXeris Biopharma to Report First Quarter 2024 Financial..
2024/4/0405:05BWXeris Pharmaceuticals Announces Inducement Grants Under..
2024/4/0220:00BWXeris Biopharma to Participate in the 23rd Annual Needham..
2024/3/0706:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0706:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0621:27EDGAR2Form 8-K - Current report
2024/3/0621:02BWXeris Biopharma Reports Fourth Quarter and Full Year 2023..
2024/3/0621:00BWXeris Refinances Its $150M Senior Secured Term Loan Facility..
2024/2/2821:00BWXeris Biopharma to Report Fourth Quarter and Full Year 2023..
2024/2/0521:00BWXeris to Present at the Oppenheimer 34th Annual Healthcare..
2024/2/0107:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1100:12DJNXeris Biopharma Shares Climb 12% on Amgen License Agreement
2024/1/1022:53DJNXeris Biopharma Reaches License Agreement With Amgen On..
2024/1/1022:00BWXeris Biopharma Enters Into an Exclusive Worldwide License..
2024/1/0606:05BWXeris Pharmaceuticals Announces Inducement Grants Under..
2024/1/0421:09EDGAR2Form 8-K - Current report
2024/1/0421:00BWXeris Biopharma Updates Its Outlook for 2023
2023/12/2721:00BWXeris Biopharma to Present at the 42nd Annual J.P. Morgan..
2023/11/2206:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1006:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0921:20EDGAR2Form 8-K - Current report
2023/11/0921:00BWXeris Biopharma Reports Third Quarter 2023 Financial Results
2023/10/1620:12EDGAR2Form 8-K - Current report
2023/10/1620:00BWXeris Biopharma Raises Full-Year Financial Guidance and..
2023/9/3005:55EDGAR2Form 8-K - Current report
2023/9/2721:11EDGAR2Form 8-K - Current report
2023/9/2721:00BWXeris Biopharma Announces Private Convertible Note Exchange..
2023/9/1505:05BWXeris to Participate in the 2023 Cantor Global Healthcare..
2023/8/2820:00BWXeris to Participate at the H.C. Wainwright 25th Annual..
2023/8/0905:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0820:23EDGAR2Form 8-K - Current report
2023/8/0820:00BWXeris Biopharma Reports Second Quarter 2023 Financial..
2023/8/0120:00BWXeris Biopharma to Report Second Quarter 2023 Financial..
2023/7/3120:00BWXeris Ships One Millionth Gvoke® Unit
2023/6/2905:28EDGAR2Form 8-K - Current report
2023/6/2120:00BWXeris Biopharma Announces First Participant Dosed in a Phase..
2023/6/0120:00BWXeris Biopharma to Participate at the Jefferies Healthcare..
2023/5/0920:00BWXeris Biopharma Reports First Quarter 2023 Financial Results

最近閲覧した銘柄

Delayed Upgrade Clock